For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is DexCom (DXCM Quick QuoteDXCM - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

DexCom is a member of the Medical sector. This group includes 902 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. DXCM is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for DXCM's full-year earnings has moved 2.18% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Based on the latest available data, DXCM has gained about 9.82% so far this year. At the same time, Medical stocks have gained an average of 2.29%. This means that DexCom is outperforming the sector as a whole this year.

Looking more specifically, DXCM belongs to the Medical - Instruments industry, which includes 96 individual stocks and currently sits at #105 in the Zacks Industry Rank. Stocks in this group have gained about 1.32% so far this year, so DXCM is performing better this group in terms of year-to-date returns.

Investors with an interest in Medical stocks should continue to track DXCM. The stock will be looking to continue its solid performance.